Paul A. Jones Sells 6,266 Shares of USANA Health Sciences, Inc. (NYSE:USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNA) insider Paul A. Jones sold 6,266 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total value of $240,489.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

USANA Health Sciences Stock Up 2.4 %

NYSE USNA opened at $39.22 on Friday. The company has a 50-day moving average price of $44.14 and a 200-day moving average price of $46.20. USANA Health Sciences, Inc. has a 52 week low of $37.35 and a 52 week high of $65.46. The firm has a market capitalization of $747.18 million, a P/E ratio of 12.22, a PEG ratio of 1.30 and a beta of 0.90.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, July 23rd. The company reported $0.54 EPS for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.11). The business had revenue of $212.87 million for the quarter, compared to analysts’ expectations of $218.64 million. USANA Health Sciences had a net margin of 6.29% and a return on equity of 11.13%. During the same period in the prior year, the company posted $0.89 earnings per share. As a group, equities research analysts anticipate that USANA Health Sciences, Inc. will post 2.5 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on USNA. StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th. DA Davidson cut their price objective on USANA Health Sciences from $46.00 to $38.00 and set a “neutral” rating for the company in a report on Thursday, July 25th.

Hedge Funds Weigh In On USANA Health Sciences

Several institutional investors and hedge funds have recently bought and sold shares of USNA. CWM LLC raised its stake in shares of USANA Health Sciences by 21.8% in the first quarter. CWM LLC now owns 1,543 shares of the company’s stock worth $75,000 after buying an additional 276 shares during the period. New York State Common Retirement Fund increased its holdings in USANA Health Sciences by 1.2% in the 4th quarter. New York State Common Retirement Fund now owns 24,500 shares of the company’s stock worth $1,313,000 after acquiring an additional 279 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in USANA Health Sciences by 9.2% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock worth $284,000 after acquiring an additional 494 shares during the period. Strs Ohio lifted its holdings in USANA Health Sciences by 9.2% during the fourth quarter. Strs Ohio now owns 11,900 shares of the company’s stock valued at $637,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Quest Partners LLC purchased a new position in USANA Health Sciences during the fourth quarter valued at approximately $66,000. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.